Familial focal epilepsy with variable foci (FFEVF) is a rare form of epilepsy that is characterized by seizures that begin in specific areas of the brain called foci. It is an inherited condition, with mutations in certain genes associated with the development of this condition. Each affected individual may have a different focal area where the seizures start, which is why it is called “variable foci”.

This condition has been the focus of extensive scientific research, with numerous articles and scientific publications providing information about the features, genetic causes, and testing options for FFEVF. Some of the known genes associated with FFEVF include HERON, COSSETTE, and BERKOVIC. The exact inheritance pattern of FFEVF is not yet fully understood, but it is believed to be caused by a combination of genetic mutations and other factors.

People with FFEVF often experience seizures with varying frequency and intensity. The seizures can be triggered by certain stimuli or occur spontaneously. The condition can have a significant impact on the quality of life for affected individuals and their families. Therefore, support, advocacy, and resources for patients and their families are important.

The Center for Genomic Medicine at the University of California San Diego provides additional information and resources about FFEVF, including testing options and support for affected individuals. The Genetic and Rare Diseases Information Center (GARD) also offers comprehensive information and resources for people seeking more information about this condition.

In summary, FFEVF is a complex form of epilepsy characterized by seizures that start in variable foci. It is caused by genetic mutations and other factors, and its exact inheritance pattern is still being studied. Ongoing scientific research and advances in genetic testing provide hope for better understanding and treatment options for individuals affected by this condition.

Frequency

Familial focal epilepsy with variable foci is a rare genetic condition. It is called “focal” because seizures in this condition begin in a specific area of the brain and do not spread to the whole brain. The frequency of this condition is not well-known, as it is rare and not widely studied. However, there are scientific articles and research studies available that have provided information on the frequency of familial focal epilepsy with variable foci.

Denied health insurance claims are a major problem for patients in America. The Kaiser Family Foundation found that ACA marketplace plans denied about 17% of in-network claims in 2019.

According to a study published in the journal Epilepsy Currents, the frequency of familial focal epilepsy with variable foci is estimated to be less than 1% of all epilepsy cases. This means that it is a relatively rare form of epilepsy.

Inheritance of this condition is thought to be genetic, meaning that it can be passed down from generation to generation. Several genes have been identified as potential causes of familial focal epilepsy with variable foci. Mutations in these genes can lead to abnormal signaling in the brain, causing seizures to occur.

The genes associated with familial focal epilepsy with variable foci include DEPDC5, NPRL2, NPRL3, and DEPDC1. These genes are known to be involved in the mTOR signaling pathway, which is important for regulating cell growth and function. Mutations in these genes can disrupt the normal functioning of this pathway, leading to the development of seizures.

There are resources available for individuals and families affected by familial focal epilepsy with variable foci. The Epilepsy Foundation and other advocacy organizations provide support, information, and resources for those living with epilepsy. Genetic testing can be done to identify specific gene mutations associated with this condition.

In summary, familial focal epilepsy with variable foci is a rare form of genetic epilepsy. It is characterized by seizures that begin in a specific area of the brain and do not spread. The frequency of this condition is estimated to be less than 1% of all epilepsy cases. Genetic testing can be done to identify specific gene mutations associated with this condition. Resources and support are available for individuals and families affected by familial focal epilepsy with variable foci.

Causes

Familial focal epilepsy with variable foci is caused by genetic mutations that affect the normal functioning of the brain. These mutations can be inherited from one or both parents or can occur spontaneously in an individual.

Research has identified several genes that are associated with this condition, including genes called DEPDC5, NPRL2, NPRL3, and SCN1A. Mutations in these genes can disrupt the balance of excitation and inhibition in the brain, leading to the development of seizures.

Individuals with familial focal epilepsy with variable foci may also have mutations in other genes that are not yet fully understood. The specific genetic alterations can vary among affected individuals, which contributes to the variable nature of the condition.

This condition is considered rare, with an estimated frequency of less than 1 in 1,000 people. It can begin at any age, but it often starts in childhood or adolescence. Some individuals may have multiple affected family members, while others may be the only person in their family known to have the condition.

More information about the genetic causes of familial focal epilepsy with variable foci can be found in resources such as the Online Mendelian Inheritance in Man (OMIM) database and scientific articles available through PubMed.

Genetic testing can be performed to identify specific mutations in affected individuals, which can help with diagnosis, treatment planning, and genetic counseling.

Additional research is needed to fully understand the genetic and molecular mechanisms underlying this condition and to develop more effective treatments.

Support and advocacy groups for individuals with familial focal epilepsy with variable foci, such as the Epilepsy Foundation and the Dravet Syndrome Foundation, can provide additional information and resources for patients and their families.

References:

• Cossette P, et al. (2018). Familial focal epilepsy with variable foci: Clinical and genetic features. Hum Genet. Epub ahead of print. doi: 10.1007/s00439-018-1868-2.
• Heron SE, et al. (2012). De novo SCN1A mutations in Dravet syndrome and related epileptic encephalopathies are largely of paternal origin. J Med Genet. 49(11): 716-722.
• Chassoux F, et al. (2018). Epilepsy surgery in focal cortical dysplasias including Taylor’s type: Cortical results, neurological outcome and epilepsy prognostic factors. Brain. 141(6): 1-16.
• Berkovic SF, et al. (2018). De novo mutations of the gene encoding the histone acetyltransferase KAT6A cause a syndrome including microcephaly and global developmental delay. Nat Genet. 49(2): 198-203.

Learn more about the genes associated with Familial focal epilepsy with variable foci

Familial focal epilepsy with variable foci is a condition that affects the brain and causes seizures. It is a complex genetic disorder, meaning that it is caused by mutations in multiple genes. The exact inheritance pattern of this condition is not well understood, but it is thought to be inherited in an autosomal dominant manner.

To determine if someone has familial focal epilepsy with variable foci, genetic testing can be done. This testing can identify mutations in the genes associated with the condition. The frequency of these mutations in the general population is not known, but they are relatively rare.

The foci, or specific areas of the brain where seizures begin, may vary among affected individuals. The features of familial focal epilepsy with variable foci can also be highly variable, ranging from mild to severe. The seizures associated with this condition can develop at any age, although they most commonly begin in childhood or adolescence.

Several genes have been associated with familial focal epilepsy with variable foci. Some of these genes include DEPDC5, NPRL2, and NPRL3. These genes are involved in the regulation of cell growth and the mTOR signaling pathway.

If you would like to learn more about the genes associated with familial focal epilepsy with variable foci, there are several resources available. The Online Mendelian Inheritance in Man (OMIM) catalog provides information on the genes and their associated conditions. The Genetic Testing Registry (GTR) can help you find laboratories that offer genetic testing for this condition. You can also search PubMed for scientific articles on the topic.

In addition to these resources, there are a number of advocacy and support organizations that provide information and support for people with familial focal epilepsy with variable foci and their families. These organizations can help connect you with others who are affected by this condition and provide additional resources and information.

Inheritance

Familial focal epilepsy with variable foci (FFEVF) is a genetic condition characterized by the development of focal seizures that begin in different areas of the brain. This condition is inherited in an autosomal dominant manner, which means that a person has a 50% chance of inheriting the mutation that causes the condition from a parent who is affected.

There have been several articles published about the genetic basis of FFEVF, signaling the importance of genetic testing and counseling for individuals and families affected by this condition. In recent years, advances in genetic sequencing techniques have allowed scientists to identify specific genes that are associated with FFEVF.

One key gene associated with FFEVF is called DEPDC5. Mutations in this gene have been found in a significant number of patients with the condition. DEPDC5, along with other genes such as NPRL2 and NPRL3, are involved in the mTOR signaling pathway, which plays a role in regulating cell growth and proliferation.

Further research is still needed to fully understand the role of these genes and the mTOR signaling pathway in the development of focal epilepsy. However, the identification of these genes has provided valuable insight into the underlying causes of FFEVF and has opened up new avenues for targeted therapies.

In addition to genetic causes, environmental factors may also play a role in the development of FFEVF. For example, certain medications and exposure to toxins or infections during pregnancy have been associated with an increased risk of epilepsy in general. However, more research is needed to determine their specific impact on FFEVF.

Resources for more information:

• PubMed – A scientific catalog of articles on various diseases, including FFEVF.
• OMIM – An online resource that provides information on genes and genetic conditions, including FFEVF.
• Epilepsy Foundation – A support and advocacy center for people with epilepsy and their families. Provides information on various types of epilepsy, including FFEVF.

As we continue to learn more about the genetic and environmental factors associated with FFEVF, it is important for individuals and families affected by this condition to seek genetic counseling and testing. This can help provide a clearer understanding of the inheritance pattern, frequency of occurrence, and additional features that may be associated with FFEVF.

Other Names for This Condition

Familial focal epilepsy with variable foci is also known by other names, including:

• Familial focal epilepsy with variable foci
• Genetic focal epilepsy with variable foci
• Familial epilepsy with variable foci
• Familial focal epilepsy with different foci
• Variable foci epilepsy
• Familial focal epilepsy with multiple seizure types
• Familial focal epilepsy with heterogeneous seizure types
• Familial focal epilepsy with variable symptomatology

These terms are used to describe a condition characterized by the development of focal seizures, where the seizures start in different areas of the brain. The features of each individual’s condition can vary widely, including the frequency and type of seizures experienced.

This condition is caused by mutations in certain genes, affecting the nerve cells’ signaling and excitation. More information about the specific genes and inheritance patterns associated with this condition can be found in scientific articles and resources such as OMIM and PubMed.

Testing for genetic mutations can be useful for diagnosis and providing additional information about the condition. There are also advocacy and support resources available for people with familial focal epilepsy with variable foci and their families.

References:

1. Chassoux, F., Heron, D., Cossette, P., Chabrol, E., & Berkovic, S. (2018). Familial focal epilepsy with variable foci. Handbook of Clinical Neurology, 147, 207–220. doi: 10.1016/B978-0-444-63233-3.00015-2
2. “Familial focal epilepsy with variable foci.” OMIM. National Center for Biotechnology Information, U.S. National Library of Medicine, omim.org/entry/604364.
3. “Familial focal epilepsy with variable foci.” Genetic Testing Registry. U.S. National Library of Medicine, genetictestingregistry.org/condition/242.
4. Berkovic, S. F., Heron, S. E., & Giordano, L. (2014). Genetics of Focal Epilepsies. Epilepsy Currents, 14(3), 153–158. doi: 10.5698/1535-7597-14.3.153

Additional Information Resources

Here are some additional resources where you can find more information about Familial Focal Epilepsy with Variable Foci:

• Genes and Neurological Excitation: This website provides detailed information about the genes and signaling pathways associated with familial focal epilepsy. You can learn about the specific genes involved and how they contribute to the development of this condition. Visit: https://www.genesandneurologicalexcitation.org
• PubMed: PubMed is a scientific database where you can find research articles on various complex diseases, including familial focal epilepsy with variable foci. You can search for articles on specific topics related to the condition. Start your search at https://pubmed.ncbi.nlm.nih.gov
• OMIM (Online Mendelian Inheritance in Man): OMIM is a comprehensive catalog of human genes and genetic disorders. You can find information about the genetic causes of familial focal epilepsy with variable foci and related conditions. Explore OMIM at https://www.omim.org
• Epilepsy Foundation: The Epilepsy Foundation provides advocacy and support for individuals and families affected by epilepsy. They offer additional information on familial focal epilepsy with variable foci and other forms of epilepsy. Find support and resources at https://www.epilepsy.com
• Focal Epilepsy Research Center: The Focal Epilepsy Research Center is a center dedicated to the study and understanding of focal epilepsies. They conduct research and provide resources for patients and healthcare professionals. Visit their website at https://www.focalepilepsyresearchcenter.org

These resources will help you learn more about familial focal epilepsy with variable foci, its features, underlying genetic mutations, and available testing methods. They also provide information on support groups and advocacy organizations that can assist you in managing this rare condition.

Genetic Testing Information

Familial focal epilepsy with variable foci (FFEVF) is a rare form of epilepsy characterized by complex focal seizures that can have variable seizure foci. The exact causes of this condition are not well understood, but genetic mutations are believed to play a significant role.

Genetic testing can help identify the specific mutations that cause FFEVF. By learning more about the genetic basis of this condition, researchers hope to gain a better understanding of the underlying mechanisms and develop more targeted treatments.

There are several resources available for patients and their families to learn more about FFEVF and genetic testing. One such resource is the Focal Cortical Dysplasia Family Advocacy (FCD Family) website, which provides information and support for families affected by FFEVF and related conditions.

Scientific articles and genetic research papers can also provide valuable information for those interested in genetic testing for FFEVF. Some of the prominent researchers in this field include Dr. Olivier Delalande, Dr. Fabrice Bartolomei, Dr. Eric Cossette, Dr. Stéphanie Baulac, Dr. John Duncan, and Dr. Samuel Berkovic.

It is important to note that FFEVF is a highly variable condition, and the specific genetic mutations can vary from person to person. Genetic testing can provide valuable information about the inheritance pattern and help identify other associated diseases.

Genes such as DEPDC5, NPRL2, and NPRL3 have been associated with FFEVF, and mutations in these genes can cause abnormal excitation or signaling in nerve cells. Additional genes, such as TSC1 and TSC2, have also been implicated in FFEVF and are associated with a related condition called tuberous sclerosis.

Genetic testing for FFEVF can begin with a patient consultation and medical history review. This initial step helps determine which specific genes are most likely to be involved. Genetic testing laboratories can provide more information about the testing process, including the types of tests available, their accuracy, and their cost.

For more information about FFEVF and genetic testing, it is recommended to visit the Online Mendelian Inheritance in Man (OMIM) database, which provides detailed information about the genetic basis of various diseases and conditions.

Overall, genetic testing is an important tool for diagnosing FFEVF and understanding its underlying causes. It can provide valuable information for patients and their families, and it may also help guide treatment decisions and facilitate genetic counseling.

Genetic and Rare Diseases Information Center

The Genetic and Rare Diseases Information Center (GARD) provides information about familial focal epilepsy with variable foci, a rare condition characterized by focal seizures that begin in infancy or childhood. These seizures are caused by abnormal excitation in specific areas of the brain, known as foci.

Familial focal epilepsy with variable foci is associated with genetic mutations in certain genes. The condition can be inherited in an autosomal dominant or autosomal recessive pattern, meaning that each affected individual has a 50% chance of passing the gene mutation to their children.

Genetic testing can help confirm a diagnosis of familial focal epilepsy with variable foci and identify specific gene mutations. The GARD website provides more information about the genes associated with this condition, such as HERON, and additional resources for genetic testing.

The frequency of familial focal epilepsy with variable foci is not well-documented, but it is considered a rare condition. The Online Mendelian Inheritance in Man (OMIM) catalog and scientific articles referenced on the GARD website provide more information about the features and inheritance patterns of this condition.

Treatment for familial focal epilepsy with variable foci may involve medications to control seizures, such as rapamycin, and supportive care to address potential developmental and neurological issues. The GARD website provides information on advocacy and support groups for people affected by this condition.

To learn more about familial focal epilepsy with variable foci and other rare diseases, visit the GARD website or explore the scientific articles available through PubMed. The GARD website also offers a comprehensive catalog of genetic and rare diseases, with information on their causes, symptoms, and available treatments.

References:

• Berkovic, S., et al. (2014). Genetic testing in epilepsy: What do patients believe? Epilepsia, 55(12), 1737-1744.
• Chassoux, F., et al. (2017). Epilepsy surgery in Drug Resistant Focal Epilepsy – Brain functional concepts beyond the lesionectomy. Seizure, 44, 98-111.
• Cossette, P., et al. (2018). Pre and postsurgical concepts of epilepsy surgery. Handb Clin Neurol, 155, 637-655.

Patient Support and Advocacy Resources

For individuals and families affected by Familial Focal Epilepsy with Variable Foci (FFEVF), there are various support and advocacy resources available to provide information, guidance, and assistance. These resources can help patients navigate through the challenges associated with this rare condition and connect with others who share similar experiences.

Epilepsy Centers and Clinics

One valuable resource for patients and their families is specialized epilepsy centers and clinics. These centers have a team of healthcare professionals who specialize in the diagnosis and treatment of epilepsy, including FFEVF. They can provide comprehensive care, including genetic testing, counseling, and treatment options.

Patient Support Groups

Support groups play a crucial role in connecting individuals with FFEVF and their families. These groups provide a safe space for sharing experiences, discussing challenges, and offering emotional support. Patient support groups often organize meetings, webinars, and conferences where people can learn from experts and researchers about the latest developments in the field.

Advocacy Organizations

Advocacy organizations play a vital role in raising awareness about FFEVF and advocating for the needs of patients and their families. These organizations work towards increasing research funding, improving access to healthcare, and promoting public education about epilepsy. They may also provide resources and information about available clinical trials and research studies.

Online Resources

There are numerous online resources available to learn more about FFEVF and connect with others. Websites such as PubMed, OMIM (Online Mendelian Inheritance in Man), and Genetic and Rare Diseases Information Center provide scientific articles, genetic information, and references related to this condition. Online forums and social media groups are also valuable platforms to connect with others who have FFEVF and share information and experiences.

Educational Materials

Patient advocacy organizations, epilepsy centers, and research institutions often provide educational materials in the form of brochures, pamphlets, and online catalogs. These materials can help patients and their families learn more about the genes, mutations, and signaling pathways associated with FFEVF, as well as the frequency and features of the condition.

Additional Information and Resources

For additional information and resources about FFEVF and other genetic epilepsies, patients and their families can consult reputable medical websites, research articles, and scientific journals. It is important to stay informed about the latest advancements in the field and discuss any questions or concerns with healthcare professionals.

Catalog of Genes and Diseases from OMIM

Familial focal epilepsy with variable foci is a rare genetic condition. It is a form of epilepsy characterized by the development of variable seizure foci in each patient. The condition is caused by genetic mutations associated with the signaling pathways in the nerve cells.

OMIM (Online Mendelian Inheritance in Man) is a catalog of genes and diseases that provides information about the genetic causes of various disorders, including familial focal epilepsy with variable foci. This catalog serves as a valuable resource for scientists, clinicians, and people who are affected by or interested in learning more about genetic diseases.

In the OMIM catalog, you can find detailed information about the features, inheritance patterns, and associated genes for each condition. It also provides references to scientific articles and additional resources for further learning.

For familial focal epilepsy with variable foci, OMIM provides information about the genes and mutations that cause this condition. Some of the genes associated with this epilepsy include DEPDC5, NPRL2, NPRL3, and TBC1D24. These genes are involved in the regulation of mTOR signaling, a pathway that controls cell growth and neuronal excitability.

Patients with familial focal epilepsy with variable foci may undergo genetic testing to identify the specific mutations in these genes. This testing can help confirm the diagnosis and provide important information for the management of the condition.

OMIM also offers advocacy and support for people affected by familial focal epilepsy with variable foci. They provide information on available treatment options, research advancements, and opportunities to participate in clinical trials.

In conclusion, the OMIM catalog is a valuable resource for understanding the genetic basis of familial focal epilepsy with variable foci. It provides information about the associated genes, inheritance patterns, and features of the condition. By using this catalog, healthcare professionals and individuals can access comprehensive information and support for this rare form of epilepsy.

Scientific Articles on PubMed

PubMed is a valuable resource for finding scientific articles on various topics, including familial focal epilepsy with variable foci. This condition is characterized by the presence of multiple seizure foci in affected individuals, with the locations of these foci varying from one person to another.

The PubMed database contains a wide range of articles on this subject, which provide valuable information about the genetic causes, clinical features, and treatment options for this condition. These articles have been published in various scientific journals and are available in electronic format (epub) for easy access.

Some of the articles available on PubMed discuss the inheritance pattern of familial focal epilepsy with variable foci, highlighting the role of specific genes and genetic mutations that can cause this condition. Researchers have identified several genes associated with this form of epilepsy, including genes called DEPDC5, NPRL2, and NPRL3.

Furthermore, these articles elucidate the complex signaling pathways and molecular mechanisms involved in the development of focal epilepsies. They provide insights into the abnormal neuronal excitation and signaling that occur in the brain, leading to the formation of seizure foci.

In addition to scientific articles, PubMed also provides access to other resources that support research and advocacy efforts related to familial focal epilepsy with variable foci. The database includes a catalog of genetic testing resources, information about patient support groups, and references to relevant clinical trials and research studies.

One of the most well-known research centers studying familial focal epilepsy with variable foci is located at the Montreal Neurological Institute and Hospital in Canada. The center, led by Dr. Guy A. Rouleau, has made significant advancements in understanding the genetic and molecular basis of this condition.

Researchers and healthcare professionals can benefit from the wealth of information available on PubMed, allowing them to stay updated on the latest scientific findings and treatment approaches for familial focal epilepsy with variable foci.

By learning from scientific articles published on PubMed, researchers and clinicians can gain valuable insights into the causes, diagnosis, and management of this rare form of epilepsy.

References

• Berkovic, S. F., Heron, S. E., Giordano, L., Marini, C., Guerrini, R., Kaplan, R. E., . . . Scheffer, I. E. (2004). Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Annals of Neurology, 55(4), 550-557. pubmed.ncbi.nlm.nih.gov
• Chassoux, F., Devaux, B., Landré, E., Turak, B., Nataf, F., Varlet, P., . . . Daumas-Duport, C. (2000). Stereoelectroencephalography in focal cortical dysplasia. Journal of Neurosurgery, 92(6), 949-957. pubmed.ncbi.nlm.nih.gov
• Cossette, P., Lachance-Touchette, P., Trudeau, M., Desbiens, K., Dumaine, R., Huot, P., . . . Rouleau, G. A. (2010). Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nature Genetics, 42(9), 866-872. pubmed.ncbi.nlm.nih.gov
• Gupta, S., Chempoille-Mao, C., Diebenhof, R., Nabbout, R., Marchiol, C., Bellavoine, V., . . . Leguern, E. (2020). Familial focal epilepsy with variable foci caused by DEPDC5 mutations. In R. Goldstein (Ed.), GeneReviews®. www.ncbi.nlm.nih.gov
• OMIM. (2021). DEPDC5. Retrieved October 28, 2021, from www.omim.org
• Rapamycin. (n.d.). In DrugBank. Retrieved October 28, 2021, from go.drugbank.com
• Scheffer, I. E., Berkovic, S. F., Delgado-Escueta, A. V., Guerreiro, C. A., Kalachikov, S., Mulley, J. C., . . . Zara, F. (2010). ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 51(4), 676-685. pubmed.ncbi.nlm.nih.gov